about
Evaluating the potential of gold, silver, and silica nanoparticles to saturate mononuclear phagocytic system tissues under repeat dosing conditions.Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis.Rosuvastatin-induced pemphigoid.A review of psoriasis, a known risk factor for cardiovascular disease and its impact on folate and homocysteine metabolismTNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.Dipeptidyl peptidase-4 inhibition and narrow-band ultraviolet-B light in psoriasis (DINUP): study protocol for a randomised controlled trial.Implementing Routine HIV Screening in Three Chicago Hospitals: Lessons LearnedCardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis.Natural killer cells in psoriasis.Innate immunity in the pathogenesis of psoriasis.Hidradenitis suppurativa: the role of immune dysregulation.Adipokines, psoriasis, systemic inflammation, and endothelial dysfunction.Hidradenitis suppurativa is characterised by dysregulation of the Th17:Treg cell axis, which is corrected by anti-TNF therapy.Anti-TNFα antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease: an Irish Cohort Study.Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.Remission of hidradenitis suppurativa after bariatric surgery.Prevalence of psoriasis in patients with alcoholic liver disease.Successful treatment of a refractory verruca in a child with acute lymphoblastic leukaemia with topical cidofovir.Etanercept treatment in Sweet's syndrome with inflammatory arthritis.Generalized pustular psoriasis (von Zumbusch) following the use of calcipotriol and betamethasone dipropionate ointment: a report of two cases.Adrenal suppression following topical use of clobetasol propionate illegally supplied as a bleaching agent.Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin.The role of eNOS phosphorylation in causing drug-induced vascular injury.Hidradenitis Suppurativa and Crohn's Disease: A Case Series.A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP).Image Gallery: Systemic sarcoidosis presenting within the black pigment of a cosmetic tattoo.Narrow-band ultraviolet B phototherapy outcomes in atopic dermatitis-A single-centre retrospective review.Nicotinamide for prevention of nonmelanoma skin cancers: a change in practice?Pancreatitis associated with calciphylaxis successfully treated with sodium thiosulfate.Patients with psoriasis are frequently using sunbeds.Assessment of a visual risk communication aid used to support patients with psoriasis in deciding about biological therapy.An unsual cause of bilateral pigmentation on the upper back.Homocysteine status and cardiovascular risk factors in patients with psoriasis: a case-control study.Autophagy in pancreatic acinar cells in caerulein-treated mice: immunolocalization of related proteins and their potential as markers of pancreatitis.Airborne contact dermatitis induced by a neighbour's beehives.Oral Sweet's syndrome occurring in ulcerative colitis.Effect of uremic serum and uremic toxins on drug metabolism in human microsomes.Framingham risk assessment in hidradenitis suppurativa.Fatigue as a symptom in psoriasis and psoriatic arthritis: an observational study.Human ß-Defensin 3 and Its Mouse Ortholog Murine ß-Defensin 14 Activate Langerhans Cells and Exacerbate Psoriasis-Like Skin Inflammation in Mice.
P50
Q33909458-B9E1923F-B7F4-4035-AE23-C9EC54A7E37FQ35285238-3E776341-0CE0-40E5-9FB0-A3387E96625BQ35957761-6BDECF34-7287-4239-B608-E53FBFD16AB8Q36012185-8800212E-D9CB-41D4-8C7F-6C14FD9DA3BFQ36029819-64CD2715-C7C4-4EF9-B386-261E69294A9EQ36466692-16FB5730-0C0A-4120-A906-41D46DAA8A77Q36484218-FDD9400B-D6F3-449C-81C7-6614BBBB0ECAQ37753594-6F52EDD9-C8AB-44C2-AE88-A4581EDCAA13Q37879879-C76E789F-DD46-4540-94E8-51635656702CQ37921634-6E15C10C-939A-454A-9E97-E571CC247EEBQ38222887-506A4AB7-99D2-42A0-AD26-CCA60D1EF8F5Q38649854-50AB2BB2-EE06-4B1B-92DA-A128B99CBF5FQ38708176-9B741E04-D249-4750-8DCD-FE384791802AQ39030512-430546A3-530F-4196-A7A2-C4C05C1585A8Q41047761-63BD6731-D869-4228-96D4-F1A51CA17B05Q41299393-56171D96-0ABA-4B8B-8469-214FFBF15B38Q42170432-58270977-4241-4DE6-84ED-6B8A4F62CFF5Q45280067-2E9FF3BB-43A4-4E38-87A3-972CC190F6F5Q45976235-78676838-611E-414E-9E20-4EF230E742DFQ45976569-62938AC2-5A37-4B2C-920B-1F9B927722E7Q46530068-D5241EF0-BFE5-457C-BBBD-AE06B6A87C7EQ46640068-DCFCDCE2-C312-4E7A-9780-12D5FA7EF265Q46909228-932B4CA0-ECCF-497F-8DEF-CBA8DDC520BEQ47573631-EBF596D7-E81F-4631-A90C-C1072BA8F0CEQ47583578-0228FF88-10B4-48DC-9171-C99486EB0AD1Q47995780-0445271A-1956-4213-9284-7F05286EF161Q48109367-68E85484-253F-4B5B-A58C-D7A4333462F8Q48168815-4AECE42C-83E5-477E-8A86-5E0C0BFEF630Q49165071-4B2E9E9A-D5F2-4995-86C7-417FCD2536DEQ49586673-39AA5535-25F8-4F6B-9198-BA2EBEE55210Q50119518-039EC2CA-F6E4-49E3-8D15-84C690276F23Q50197032-F7AE59E0-3439-46F0-8A71-475F8F8141A8Q50575042-AE9F5450-19C8-4B24-83E3-0E2D95FFD83AQ51022472-F07E5ED1-1855-4AA3-B147-528AA518F304Q52646217-67F22A52-778B-4ADC-827C-BFEBEDF19494Q52890554-3F59A70E-A1A5-4437-80AE-C23F15BCAAE3Q53084468-E34B33EB-F66B-42EB-9480-218FA46FB989Q53122374-A863EC32-D32C-4A42-924C-CDD960A1176CQ53127308-1FAB4783-16D7-4829-84E2-5C3920C7F909Q53137209-D103F0F2-9638-46A0-91B1-CB48647B17F1
P50
description
researcher
@en
wetenschapper
@nl
name
A M Tobin
@en
A M Tobin
@nl
type
label
A M Tobin
@en
A M Tobin
@nl
prefLabel
A M Tobin
@en
A M Tobin
@nl
P106
P31
P496
0000-0003-2730-9561